VDAC2 and endometrial cancer: Jóźwiak at al. have revealed that the high level of VDAC2 protein indicated a poor prognosis of endometrial cancer patients [20], which was consistent with our findings that NSCLC patients with overexpression of VDAC2 had worse prognosis.